A new P32 labelled colloidal complex was introduced into the main trunk of the portal vein of the rabbit in order to examine its fixation and distribution within the liver. The dispersion percentage of the radiocolloid in the organism was minimal. Measurement of the radioactivity and autoradiohistographies would indicate a high stability of the preparation even some time after (2 months). Results are of particular significance when compared to those obtained with the introduction of the same radiocolloid into the general circulation.
Get full access to this article
View all access options for this article.
References
1.
BellionB., BüchiG., ChiarleS., GovernaM., RosaU., e ScassellatiG. A.: Nuovo metodo di preparazione del radiofosfato di cromo colloidale. Studio sul meccanismo di formazione e sul comportamento biologico.Min Nucleare, 6: 199–208, 1962.
2.
DogliottiA. M., e CaldarolaL.: Nuovi indirizzi nella terapia regionale dei tumori maligni. Nota preventiva sull'impiego di un nuovo preparato con fosforo 32 per il trattamento regionale dei tumori maligni.Min. Medica, 53: 2607–2608, 1962.
3.
DogliottiA. M., et CaldarolaL.: Premiers résultats. L'emploi d'un nouveau complex colloïdal marqué avec le phosphore 32 (P32) dans la thérapeutique régionale des tumeurs malignes.Presse Méd., 70: 2493, 1962.
4.
LevineB., HoffmanH., and FreelanderS. O.: Distribution and effect of colloidal chromic phosphate (P32) injected into the epatic artery and portal vein of dog and man.Cancer, 10: 164–172, 1957.